What will peptide care cost?

What belongs in a written quote?

Ask for separate prices for the first visit to check your health, later visits, tests and the medicine.

Ask whether “membership” means a recurring clinic fee, what it pays for and what is billed separately.

For each charge, ask whether it repeats and whether it changes after an offer ends. Ask about cancellation terms before agreeing to the clinic’s payment arrangement.

Is the advertised price the ongoing price?

As of September 26, 2026, the recorded price offer for semaglutide (Ozempic) injection starts at $199 a month for new patients paying outside insurance.

That price applies only to the first two monthly prescription fills.

The introductory price is limited to prescriptions for two strengths: 0.25 mg or 0.5 mg.

A strength is the amount of medicine printed on a prescription; ask the pharmacist to match yours to the offer.

The offer’s later monthly prices are $349 for prescriptions marked 0.25, 0.5 or 1 mg, and $499 for those marked 2 mg.

It is for U.S. residents aged 18 or older who pay outside insurance, without asking insurance to repay them or count the payment toward a deductible.

A deductible is the amount your insurance requires you to pay before it starts paying for covered costs.

The printed offer terms run through December 31, 2026.

Ask the pharmacist whether you qualify as a new patient under the offer and what your prescription will cost after the offer ends.

What can Medicare pay?

GLP-1 is a hormone, a substance your body makes that helps control how hungry you feel and how much sugar is in your blood.

Medicines that copy it can help reduce hunger and lower blood sugar.

As of September 26, 2026, qualifying people can get certain weight-loss medicines through the temporary Medicare GLP-1 Bridge for a $50 monthly copay.

A copay is the amount the patient pays for the medicine.

The program operates outside ordinary Medicare drug coverage from its start date, July 1, 2026, through its end date, December 31, 2027.

It requires a prescription and approval before the medicine is supplied, plus the plan and health checks below.

In 2026, Medicare uses a separate service to handle the program’s approval requests, rather than sending them to your usual drug plan.

Ask the prescriber to submit the program’s approval form and check these rules with you.

As of September 26, 2026, you must be at least 18 and have drug coverage through either a standalone Medicare drug plan or a coordinated care plan under Medicare Advantage.

Ask your insurer to confirm which kind of plan you have; a Medicare card alone does not answer that question.

BMI means body mass index, a number calculated using your weight and height. Ask the prescriber to calculate it and check your medical record.

For these qualifying groups, the program checks your BMI and health conditions at the time you began the medicine:

• A BMI reading of at least 35.
• A BMI reading of at least 30, together with heart failure with preserved ejection fraction (the heart still squeezes well), high blood pressure that remains uncontrolled despite treatment, or stage 3a or later kidney disease.
• A BMI reading of at least 27, together with pre-diabetes (blood sugar above normal but below diabetes levels), a heart attack or stroke in the past, or artery disease that causes arm or leg symptoms.

For the middle group, ask the doctor to check the type of heart failure or the kidney-disease stage in your chart.

For that group’s blood-pressure rule, the upper reading must be above 140 or the lower above 90 despite two blood-pressure medicines.

People with type 2 diabetes use the ordinary drug coverage route rather than this program.

The program also excludes moderate to severe obstructive sleep apnea, meaning breathing is blocked during sleep.

Its liver exclusion is noncirrhotic MASH, a particular fatty-liver illness without the most advanced stage of scarring, when there is moderate to advanced liver scarring.

Ask the doctor to check those diagnoses; a general mention of fatty liver does not settle whether that liver exclusion applies.

A GLP-1 medicine paid for by your Medicare drug plan during 2026 rules out using the Bridge during 2026.

The prescription must also include ongoing changes to eating and physical activity.

The yearly cap on your payments for medicines under ordinary Medicare drug coverage excludes the Bridge’s $50 monthly payment.

You still pay this $50 even after reaching that yearly limit for your other covered medicines.

Have the prescriber confirm approval before counting on this price.

Does approval mean my insurance pays?

As of September 26, 2026, approval by the U.S. medicine agency does not require an insurance plan to pay for a medicine.

Ask your insurer: “Is this exact medicine covered for this use? Do you need to approve payment before the prescription is filled?”

Ask for your own cost after that approval, not just a yes or no on coverage.